As part of our continued success in supporting universities in pursuit of Medical Research Future Fund (MRFF) grants, Medcast is thrilled to announce a new collaboration with the University of Wollongong’s Graduate School of Medicine. Led by Professor Andrew Bonney, who has been awarded a $2.7 million MRFF grant, this research initiative aims to address antimicrobial resistance (AMR) in general practice.
The OPTIMAS-GP Study
The study, titled "Optimal Implementation of Antimicrobial Stewardship in General Practice" (OPTIMAS-GP), focuses on reducing the inappropriate prescription of antibiotics, a key factor in the development of AMR. General practitioners (GPs), often the first point of contact for patients with respiratory infections, play a vital role in this effort.
Professor Bonney
Professor Bonney’s team, which includes Medcast’s A/Prof Stephen Barnett and researchers from Bond University, Monash University, and the University of Tasmania, aims to enhance GPs' capabilities through the development of an innovative online Antimicrobial Stewardship (AMS) Toolbox. This tool is designed to support GPs in their consultations with adult patients experiencing acute respiratory infections.
Role of Medcast
Medcast is poised to make a significant contribution to the OPTIMAS-GP study by leveraging our expertise in online learning for GPs and educational technology. Our role will include:
Developing and Hosting Online Educational Content: We will assist in creating and disseminating the educational components of the AMS Toolbox.
Supporting the Randomized Controlled Trial (RCT): We will implement two evidence-based online education and audit strategies—one self-paced and the other facilitated—to determine which is more effective at improving GP practices and reducing unnecessary antibiotic prescriptions.
Why This Matters
The threat of AMR cannot be overstated—without effective antibiotics, routine infections could become more dangerous, leading to increased mortality and economic burden. By improving antibiotic prescribing practices, we can significantly reduce the risk of bacteria developing resistance.
We are excited about the potential of this partnership to transform healthcare practice and look forward to sharing updates as the project progresses.
Stephen is a GP Supervisor, Medical Educator, GP academic and Medical Director of Medcast. He has completed a PhD on Virtual Communities of Practice in GP Training.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreCrohn’s disease (CD) is a chronic inflammatory bowel disease affecting any part of the GI tract. It has genetic and environmental triggers and presents with symptoms like abdominal pain, diarrhoea, and weight loss. Diagnosis involves endoscopy and imaging. Management includes corticosteroids, biologics, immunomodulators, lifestyle changes, and psychological support. This FastTrack-CPD provides a clinical summary on the management of Crohn's disease with a quiz to apply your learning and receive CPD (RP and EA categories).
Polycystic ovary syndrome (PCOS) affects 10–13% of women, with higher prevalence in certain ethnic groups. It is characterized by hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology. PCOS increases the risk of type 2 diabetes, cardiovascular disease, and requires early diagnosis and personalized management to reduce long-term effects. This FastTrack-CPD provides a clinical summary on the management of PCOS with a quiz to apply your learning and receive CPD (RP and EA categories).
A chalazion is a painless, chronic eyelid swelling caused by a blocked meibomian gland, leading to granulomatous inflammation. It can persist for weeks to months and is more common in adults. Risk factors include blepharitis, ocular rosacea, and seborrhoeic dermatitis. This FastTrack-CPD provides a clinical summary on the management of chalazion with a quiz to apply your learning and receive CPD (RP and EA categories).